The global Dry Powder Inhalation Excipients market size is predicted to grow from US$ 1695 million in 2024 to US$ 2351 million in 2030; it is expected to grow at a CAGR of 5.6% from 2024 to 2030.

Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.

United States market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Dry Powder Inhalation Excipients players cover Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

Infinity Market Research newest research report, the Dry Powder Inhalation Excipients Industry Forecast looks at past sales and reviews total world Dry Powder Inhalation Excipients sales in 2023, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Excipients sales for 2024 through 2030. With Dry Powder Inhalation Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Excipients industry.

This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Dry Powder Inhalation Excipients market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Excipients.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Excipients market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Lactose
    Magnesium Stearate
    Others

Segmentation by Application:

    DPI
    MDI
    Nebulizer
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Protheragen-ING
    DFE Pharma
    Meggle-Pharma
    Pfanstiehl
    Merck
    Sheffield (Kerry)
    Armor Pharma
    Abbott
    Norvatis
    Bayer
    Jiangsu Daoning Drug

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dry Powder Inhalation Excipients market?
What factors are driving Dry Powder Inhalation Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dry Powder Inhalation Excipients market opportunities vary by end market size?
How does Dry Powder Inhalation Excipients break out by Type, by Application?